Clinical utility of chromogranin A in SDHx-related paragangliomas

European Journal of Clinical Investigation

Volumn 44, Issue 4, 2014, Pages 365-371

  Zuber, Samuel ^a   Wesley, Robert ^b   Prodanov, Tamara ^a   Eisenhofer, Graeme ^c   Pacak, Karel ^a   Kantorovich, Vitaly ^d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Chromogranin a; Metanephrines; Metastatic sDHB; Paraganglioma; Pheochromocytoma; SDHD

Indexed keywords

CHROMOGRANIN A; NORMETADRENALIN; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE SUBUNIT B; SUCCINATE DEHYDROGENASE SUBUNIT D; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE MUTATION; HUMAN; MALE; METASTASIS; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS;

CHROMOGRANIN A; METANEPHRINES; METASTATIC SDHB; PARAGANGLIOMA; PHEOCHROMOCYTOMA; SDHD;

ADULT; AGED; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHROMOGRANIN A; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; MUTATION; NORMETANEPHRINE; PARAGANGLIOMA; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; SUCCINATE DEHYDROGENASE; YOUNG ADULT;

EID: 84895930906     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12245     Document Type: Article

References (34)

1. Gimenez-Roquelpo AP, Dahia PL, Robledo M. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res 2012;44:328-33.
2. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002;287:1427-34.
3. Eisenhofer G, Lenders JW, Pacak K. Biochemical diagnosis of pheochromocytoma. Front Horm Res 2004;31:76-106.
4. Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC et al. Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma. Clin Chem 2011;57:411-20.
5. Timmers HJ, Pacak K, Huynh TT, Abu-Asab M, Tsokos M, Merino MJ et al. Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene. J Clin Endocrinol Metab 2008;93:4826-32.
6. Benn DE, Croxson MS, Tucker K, Bambach CP, Richardson AL, Delbridge L et al. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas. Oncogene 2003;22:1358-64.
7. Burnichon N, Rohmer V, Amar L, Herman P, Leboulleux S, Darrouzet V et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab 2009;94:2817-27.
8. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812-8.
9. Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM et al. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer 2010;18:97-111.
10. Timmers HJLM, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D et al. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 2007;92:779-86.
11. Neumann HPH, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-51.
12. Eisenhofer G, Lenders JW, Goldstein DS, Mannelli M, Csako G, Walther MM et al. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines. Clin Chem 2005;51:735-44.
13. Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW et al. Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab 2005;90:2068-75.
14. Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 2001;86:5210-6.
15. O'Connor D, Deftos L. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 1986;314:1145-51.
16. Kim T, Tao-Cheng J-H, Eiden LE, Loh YP. Chromogranin A, an on/off switch controlling dense-core secretory granule biogenesis. Cell 2001;106:499-509.
17. Modlin I, Gustafsson B, Moss S, Pavel M, Tsolakis A, Kidd M. Chromogranin A-biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol 2010;17:2427-43.
18. Vinik AI, Silva MP, Woltering EA, Go VL, Warner R, Caplin M. Biochemical testing for neuroendocrine tumors. Pancreas 2009;38:876-89.
19. Giovanella L, Squin N, Ghelfo A, Ceriani L. Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123-I-MIBG scan. Q J Nucl Med Mol Imaging 2006;50:344-7.
20. Algeciras-Schimnich A, Preissner CM, Young WF Jr, Singh RJ, Grebe SKG. Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma. J Clin Endocrinol Metab 2008;93:91-5.
21. Hsiao RJ, Neumann HP, Parmer RJ, Barbosa JA, O'Connor DT. Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution. Am J Med 1990;88:607-13.
22. Guignat L, Bidart JM, Nocera M, Comoy E, Schlumberger M, Baudin E. Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma. Br J Cancer 2001;84:808-12.
23. Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G et al. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst 2012;104:700-8.
24. Willemsen J, Ross H, Jacobs M, Lenders J, Thien T, Swinkels L et al. Highly sensitive and specific HPLC with fluorometric detection for determination of plasma epinephrine and norepinephrine applied to kinetic studies in humans. Clin Chem 1995;41:1455-60.
25. Lenders J, Eisenhofer G, Armando I, Keiser H, Goldstein D, Kopin I. Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem 1993;39:97-103.
26. Eisenhofer G, Goldstein D, Stull R, Keiser H, Sunderland T, Murphy D et al. Simultaneous liquid-chromatographic determination of 3, 4- dihydroxyphenylglycol, catecholamines, and 3, 4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem 1986;32:2030-3.
27. Tramonti G, Ferdeghini M, Annichiarico C, Norpoth M, Donadio C, Bianchi R et al. Relationship between renal function and blood level of chromogranin A. Ren Fail 2001;23:449-57.
28. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54.
29. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3, 418 individuals with CKD. Am J Kidney Dis 2008;51:395-406.
30. Barakat MT, Meeran K, Bloom SR. Neuroendocrine tumours. Endocr Relat Cancer 2004;11:1-18.
31. Hsiao RJ, Parmer RJ, Takiyyuddin MA, O'Connor DT. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine (Baltimore) 1991;70:33-45.
32. Grossrubatscher E, Dalino P, Vignati F, Gambacorta M, Pugliese R, Boniardi M et al. The role of chromogranin A in the management of patients with phaeochromocytoma. Clin Endocrinol (Oxf) 2006;65:287-93.
33. Giovanella L, Ceriani L, Balerna M, Keller F, Taborelli M, Marone C et al. Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy in patients with adrenal incidentalomas. Q J Nucl Med Mol Imaging 2008;52:84-8.
34. DeLong ER, Delong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating curves: a nonparametric approach. Biometrics 1988;44:837-45.